IAVI Begins First-in-Human Phase 1 Trial of Single-Dose Marburg Virus Vaccine Candidate

Trial to generate foundational human safety and immunogenicity data, advancing a vaccine platform suited for rapid outbreak ...
Nasdaq

Cyclo Therapeutics Presents Positive Data From Phase 3 NPC1 Sub-Study

(RTTNews) - Cyclo Therapeutics, Inc. (CYTH) on Friday announced promising preliminary data from its ongoing Phase 3 TransportNPC study, evaluating Trappsol Cyclo for the treatment of Niemann-Pick ...
Healio

Amycretin reduces weight, HbA1c in phase 2 trial of patients with diabetes

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A novel GLP-1 and amylin receptor agonist reduced HbA1c ...
Business Wire

Pelage Pharmaceuticals Announces Positive Phase 2a Clinical Trial Results for PP405 in Regenerative Hair Loss Therapy

LOS ANGELES--(BUSINESS WIRE)--Pelage Pharmaceuticals, a clinical-stage regenerative medicine company, today announced positive results from its Phase 2a clinical trial of PP405 — a topical therapy for ...
Business Wire

Equillium Announces Positive Data from Phase 2 Study Evaluating Itolizumab in Patients with Moderate to Severe Ulcerative Colitis

LA JOLLA, Calif.--(BUSINESS WIRE)--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe ...